Daniel Dix

Person

Langrangeville, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Stabilized formulations containing anti-interleukin-4 receptor (IL-...
- Patent number 11,926,670
- Issue date Mar 12, 2024
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Devices and methods for overfilling drug containers
- Patent number 11,918,785
- Issue date Mar 5, 2024
- Regeneron Pharmaceuticals Inc.
- Daniel B. Dix
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Grant
Citrate buffered VEGF antagonist formulations
- Patent number 11,806,398
- Issue date Nov 7, 2023
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 11,732,024
- Issue date Aug 22, 2023
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-PCSK9 antibodies
- Patent number 11,673,967
- Issue date Jun 13, 2023
- REGENERON PHARMACEUTICALS, INC.
- Scott M. Walsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Devices and methods for overfilling drug containers
- Patent number 11,577,025
- Issue date Feb 14, 2023
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Grant
Stabilized formulations containing anti-interleukin-6 receptor (IL-...
- Patent number 11,098,127
- Issue date Aug 24, 2021
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 11,084,865
- Issue date Aug 10, 2021
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and formulations for treating vascular eye diseases using a...
- Patent number 11,071,780
- Issue date Jul 27, 2021
- REGENERON PHARMACEUTICALS, INC.
- Robert L. Vitti
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 11,066,458
- Issue date Jul 20, 2021
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stabilized formulations containing anti-interleukin-4 receptor (IL-...
- Patent number 11,059,896
- Issue date Jul 13, 2021
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulations of VEG antagonist fusion proteins and method of manufa...
- Patent number 10,857,231
- Issue date Dec 8, 2020
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-PCSK9 antibodies
- Patent number 10,752,701
- Issue date Aug 25, 2020
- REGENERON PHARMACEUTICALS, INC.
- Scott M. Walsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-PCSK9 antibodies
- Patent number 10,472,425
- Issue date Nov 12, 2019
- REGENERON PHARMACEUTICALS, INC.
- Scott M. Walsh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 10,464,992
- Issue date Nov 5, 2019
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stabilized formulations containing anti-interleukin-4 receptor (IL-...
- Patent number 10,435,473
- Issue date Oct 8, 2019
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of manufacturing VEGF antagonist fusion proteins
- Patent number 10,406,226
- Issue date Sep 10, 2019
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 10,400,025
- Issue date Sep 3, 2019
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for reducing subvisible particles in a pharmaceutical formu...
- Patent number 10,342,876
- Issue date Jul 9, 2019
- REGENERON PHARMACEUTICALS, INC.
- Hanne Bak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-interleukin-6 receptor (IL-...
- Patent number 10,072,086
- Issue date Sep 11, 2018
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 9,914,763
- Issue date Mar 13, 2018
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-DLL4 antibodies
- Patent number 9,675,692
- Issue date Jun 13, 2017
- REGENERON PHARMACEUTICALS, INC.
- Scott Walsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF specific fusion protein antagonist formulations
- Patent number 9,636,400
- Issue date May 2, 2017
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF antagonist formulations suitable for intravitreal administration
- Patent number 9,580,489
- Issue date Feb 28, 2017
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stable VEGF antagonist formulations
- Patent number 9,511,140
- Issue date Dec 6, 2016
- REGENERON PHARMACEUTICALS, INC.
- Daniel Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stable liquid formulations of dimer VEGF antagonists
- Patent number 9,416,167
- Issue date Aug 16, 2016
- REGENERON PHARMACEUTICALS, INC.
- Daniel Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-Ang2 antibodies
- Patent number 9,402,898
- Issue date Aug 2, 2016
- REGENERON PHARMACEUTICALS, INC.
- Scott M. Walsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF antagonist formulations for intravitreal administration
- Patent number 9,340,594
- Issue date May 17, 2016
- REGENERON PHARMACEUTICALS, INC.
- Eric Furfine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-interleukin-4 receptor (IL-...
- Patent number 9,238,692
- Issue date Jan 19, 2016
- REGENERON PHARMACEUTICALS, INC.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized formulations containing anti-PCSK9 antibodies
- Patent number 9,193,801
- Issue date Nov 24, 2015
- REGENERON PHARMACEUTICALS, INC.
- Scott M. Walsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
STABILIZED FORMULATIONS CONTAINING ANTI-PCSK9 ANTIBODIES
- Publication number 20230406959
- Publication date Dec 21, 2023
- Regeneron Pharmaceuticals, Inc.
- Scott M. Walsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20230374108
- Publication date Nov 23, 2023
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEVICES AND METHODS FOR OVERFILLING DRUG CONTAINERS
- Publication number 20230158237
- Publication date May 25, 2023
- REGENERON PHARMACEUTICALS INC.
- Daniel B. DIX
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Application
Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-...
- Publication number 20210403581
- Publication date Dec 30, 2021
- Regeneron Pharmaceuticals, Inc.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF Antagonist Formulations
- Publication number 20210393778
- Publication date Dec 23, 2021
- Regeneron Pharmaceuticals, Inc.
- Daniel B. DIX
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF Antagonist Formulations
- Publication number 20210393530
- Publication date Dec 23, 2021
- Regeneron Pharmaceuticals, Inc.
- Daniel B. DIX
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20210340220
- Publication date Nov 4, 2021
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VEGF Antagonist Formulations
- Publication number 20210252105
- Publication date Aug 19, 2021
- Regeneron Pharmaceuticals, Inc.
- Daniel B. DIX
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF Antagonist Formulations
- Publication number 20210252147
- Publication date Aug 19, 2021
- Regeneron Pharmaceuticals, Inc.
- Daniel B. DIX
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-...
- Publication number 20210230283
- Publication date Jul 29, 2021
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Formulations Containing Anti-NGF Antibodies
- Publication number 20210107974
- Publication date Apr 15, 2021
- Regeneron Pharmaceuticals, Inc.
- Scott WALSH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF Antagonist Formulations
- Publication number 20210077624
- Publication date Mar 18, 2021
- Regeneron Pharmaceuticals, Inc.
- Daniel B. DIX
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABILIZED FORMULATIONS CONTAINING ANTI-PCSK9 ANTIBODIES
- Publication number 20210054100
- Publication date Feb 25, 2021
- Regeneron Pharmaceuticals, Inc.
- Scott M. Walsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEVICES AND METHODS FOR OVERFILLING DRUG CONTAINERS
- Publication number 20200155760
- Publication date May 21, 2020
- REGENERON PHARMACEUTICALS INC.
- Daniel B. DIX
- B65 - CONVEYING PACKING STORING HANDLING THIN OR FILAMENTARY MATERIAL
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20200131246
- Publication date Apr 30, 2020
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20200017572
- Publication date Jan 16, 2020
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD OF MANUFACTURING VEGF ANTAGONIST FUSION PROTEINS
- Publication number 20190388539
- Publication date Dec 26, 2019
- Regeneron Pharmaceuticals, Inc.
- Daniel B. DIX
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-...
- Publication number 20190367624
- Publication date Dec 5, 2019
- Regeneron Pharmaceuticals, Inc.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABILIZED FORMULATIONS CONTAINING ANTI-PCSK9 ANTIBODIES
- Publication number 20190284301
- Publication date Sep 19, 2019
- Regeneron Pharmaceuticals, Inc.
- Scott M. Walsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR REDUCING SUBVISIBLE PARTICLES IN A PHARMACEUTICAL FORMU...
- Publication number 20190231877
- Publication date Aug 1, 2019
- Hanne BAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES
- Publication number 20190117767
- Publication date Apr 25, 2019
- Regeneron Pharmaceuticals, Inc.
- Robert L. VITTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20190031735
- Publication date Jan 31, 2019
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES
- Publication number 20190010222
- Publication date Jan 10, 2019
- Regeneron Pharmaceuticals, Inc.
- Scott WALSH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-...
- Publication number 20190002574
- Publication date Jan 3, 2019
- Regeneron Pharmaceuticals, Inc.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20180155408
- Publication date Jun 7, 2018
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Formulations Containing Anti-PCSK9 Antibodies
- Publication number 20180044436
- Publication date Feb 15, 2018
- Regeneron Pharmaceuticals, Inc.
- Scott M. Walsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-...
- Publication number 20180002426
- Publication date Jan 4, 2018
- Regeneron Pharmaceuticals, Inc.
- Daniel B. Dix
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF ANTAGONIST FORMULATIONS
- Publication number 20170360930
- Publication date Dec 21, 2017
- Regeneron Pharmaceuticals, Inc.
- Daniel B. DIX
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES
- Publication number 20170080086
- Publication date Mar 23, 2017
- Regeneron Pharmaceuticals, Inc.
- Robert L. VITTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF ANTAGONIST FORMULATIONS
- Publication number 20170073407
- Publication date Mar 16, 2017
- Regeneron Pharmaceuticals, Inc.
- Daniel B. DIX
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Stabilized formulations containing anti-interleukin-4 receptor (IL-...

Devices and methods for overfilling drug containers

Citrate buffered VEGF antagonist formulations

VEGF antagonist formulations suitable for intravitreal administration

Stabilized formulations containing anti-PCSK9 antibodies

Devices and methods for overfilling drug containers

Stabilized formulations containing anti-interleukin-6 receptor (IL-...

VEGF antagonist formulations suitable for intravitreal administration

Methods and formulations for treating vascular eye diseases using a...

VEGF antagonist formulations suitable for intravitreal administration

Stabilized formulations containing anti-interleukin-4 receptor (IL-...

Formulations of VEG antagonist fusion proteins and method of manufa...

Stabilized formulations containing anti-PCSK9 antibodies

Stabilized formulations containing anti-PCSK9 antibodies

VEGF antagonist formulations suitable for intravitreal administration

Stabilized formulations containing anti-interleukin-4 receptor (IL-...

Method of manufacturing VEGF antagonist fusion proteins

VEGF antagonist formulations suitable for intravitreal administration

Process for reducing subvisible particles in a pharmaceutical formu...

Stabilized formulations containing anti-interleukin-6 receptor (IL-...

VEGF antagonist formulations suitable for intravitreal administration

Stabilized formulations containing anti-DLL4 antibodies

VEGF specific fusion protein antagonist formulations

VEGF antagonist formulations suitable for intravitreal administration

Stable VEGF antagonist formulations

Stable liquid formulations of dimer VEGF antagonists

Stabilized formulations containing anti-Ang2 antibodies

VEGF antagonist formulations for intravitreal administration

Stabilized formulations containing anti-interleukin-4 receptor (IL-...

Stabilized formulations containing anti-PCSK9 antibodies

Patents Applicationslast 30 patents

STABILIZED FORMULATIONS CONTAINING ANTI-PCSK9 ANTIBODIES

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

DEVICES AND METHODS FOR OVERFILLING DRUG CONTAINERS

Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-...

VEGF Antagonist Formulations

VEGF Antagonist Formulations

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

VEGF Antagonist Formulations

VEGF Antagonist Formulations

Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-...

Stabilized Formulations Containing Anti-NGF Antibodies

VEGF Antagonist Formulations

STABILIZED FORMULATIONS CONTAINING ANTI-PCSK9 ANTIBODIES

DEVICES AND METHODS FOR OVERFILLING DRUG CONTAINERS

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

METHOD OF MANUFACTURING VEGF ANTAGONIST FUSION PROTEINS

Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-...

STABILIZED FORMULATIONS CONTAINING ANTI-PCSK9 ANTIBODIES

PROCESS FOR REDUCING SUBVISIBLE PARTICLES IN A PHARMACEUTICAL FORMU...

METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES

Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-...

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

Stabilized Formulations Containing Anti-PCSK9 Antibodies

Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-...

VEGF ANTAGONIST FORMULATIONS

METHODS AND FORMULATIONS FOR TREATING VASCULAR EYE DISEASES

VEGF ANTAGONIST FORMULATIONS